Tom Gilmore

Research Coordinator II

Is this your profile? Click to edit

Publications

Once-Weekly Semaglutide in Adults With Daily Cigarette Use: A Randomized Clinical Trial. JAMA Netw Open. 2026 May 01; 9(5):e2614898.. View in PubMed
Lipopolysaccharide and imiquimod stimulation of potential immune biomarkers in whole blood predict alcohol use disorder risk based on AUDIT scores. Alcohol Clin Exp Res (Hoboken). 2026 Feb; 50(2):e70236.. View in PubMed
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2025 Apr 01; 82(4):395-405.. View in PubMed
Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in Humans. J Med Chem. 2017 06 08; 60(11):4657-4664.. View in PubMed
Discovery of diamide compounds as diacylglycerol acyltransferase 1 (DGAT1) inhibitors. Bioorg Med Chem Lett. 2016 Feb 15; 26(4):1245-8.. View in PubMed
A new structural alert for benzimidazoles: 2,6-dimethylphenyl substituents increase mutagenic potential and time-dependent CYP3A4 inhibition risk. Bioorg Med Chem Lett. 2011 Mar 01; 21(5):1422-4.. View in PubMed